Lineage commitment is a developmental process by which individual CD4+CD8+ (double positive, DP) thymocytes make a decision to differentiate into either CD4+ or CD8+ T cells. However, the molecular event(s) that defines lineage commitment is controversial. We have previously proposed that lineage commitment in DP thymocytes can be molecularly defined as the selective termination of CD4 or CD8 coreceptor synthesis. The present study supports such a molecular definition by showing that termination of either CD4 or CD8 synthesis is a highly regulated event that is only evident within the most differentiated DP subset (CD5hiCD69hiTCRhibcl-2hi). In fact, essentially all cells within this DP subset actively synthesize only one coreceptor molecule. In addition, the present results identify three distinct subpopulations of DP thymocytes that define the developmental progression of the lineage commitment process and demonstrate that lineage commitment is coincident with upregulation of TCR and bcl-2. Thus, this study supports a molecular definition of lineage commitment and uniquely identifies TCRhibcl-2hi DP thymocytes as cells that are already committed to either the CD4 or CD8 T cell lineage.
Skip Nav Destination
Article navigation
1 December 1996
Article Contents
Article|
December 01 1996
Lineage Commitment in the Thymus: Only the Most Differentiated (TCRhibcl-2hi) Subset of CD4+CD8+Thymocytes Has Selectively Terminated CD4 or CD8 Synthesis
Jennifer A. Punt,
Jennifer A. Punt
From the Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Search for other works by this author on:
Harumi Suzuki,
Harumi Suzuki
From the Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Search for other works by this author on:
Larry G. Granger,
Larry G. Granger
From the Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Search for other works by this author on:
Susan O. Sharrow,
Susan O. Sharrow
From the Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Search for other works by this author on:
Alfred Singer
Alfred Singer
From the Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Search for other works by this author on:
Jennifer A. Punt
,
Harumi Suzuki
,
Larry G. Granger
,
Susan O. Sharrow
,
Alfred Singer
From the Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Address correspondence to Alfred Singer, Experimental Immunology Branch, NCI/NIH, Building 10 Room 4B-17, Bethesda, MD 20892. Dr. Punt's current address is Haverford College, Biology Department, 370 Lancaster Avenue, Haverford, PA 19041.
1 Abbreviations used in this paper: DN, double negative; DP, double positive; SP, single positive.
Received:
September 04 1996
Revision Received:
October 04 1996
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1996
J Exp Med (1996) 184 (6): 2091–2100.
Article history
Received:
September 04 1996
Revision Received:
October 04 1996
Citation
Jennifer A. Punt, Harumi Suzuki, Larry G. Granger, Susan O. Sharrow, Alfred Singer; Lineage Commitment in the Thymus: Only the Most Differentiated (TCRhibcl-2hi) Subset of CD4+CD8+Thymocytes Has Selectively Terminated CD4 or CD8 Synthesis. J Exp Med 1 December 1996; 184 (6): 2091–2100. doi: https://doi.org/10.1084/jem.184.6.2091
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement